Matthew W. Davis

High versus low dosing of oral colchicine for early acute gout flare: Twenty‐four–hour outcome of the first multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group, dose‐comparison colchicine study

Robert Terkeltaub, Daniel E. Furst, Katherine Bennett et al. · Arthritis & Rheumatism · 2010 · 530 citations

Medicine, Pharmacology, Pharmacotherapy +16

Novel evidence‐based colchicine dose‐reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P‐glycoprotein inhibitors

Robert Terkeltaub, Daniel E. Furst, Jennifer L. DiGiacinto et al. · Arthritis & Rheumatism · 2011 · 229 citations

Medicine, Pharmacokinetics, Pharmacology +17

Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019

Christina Price, Frederick L. Altice, Yu Shyr et al. · CHEST Journal · 2020 · 215 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +11

Pharmacokinetics and Tolerability of Lidocaine Patch 5% with Extended Dosing

Arnold R. Gammaitoni, Matthew W. Davis · Annals of Pharmacotherapy · 2002 · 111 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Lidocaine Patch 5% Reduces Pain Intensity and Interference with Quality of Life in Patients With Postherpetic Neuralgia: An Effectiveness Trial

Nathaniel P. Katz, Arnold R. Gammaitoni, Matthew W. Davis et al. · Pain Medicine · 2002 · 96 citations

Medicine, Neurology, Pharmacotherapy +17